Literature DB >> 8346175

Adhesion onto and invasion into mammalian cells by mycoplasma penetrans: a newly isolated mycoplasma from patients with AIDS.

S C Lo1, M M Hayes, H Kotani, P F Pierce, D J Wear, P B Newton, J G Tully, J W Shih.   

Abstract

The newly identified mycoplasma, Mycoplasma pentrans shows remarkable pathobiologic properties: it adheres to cell surfaces, deeply penetrates into the cell, strongly hemadsorbs human red blood cells, and cytadsorbs human CD4+ lymphocytes and monocytes. These in vitro biologic activities of mycoplasmas have been previously shown to be associated with pathogenic virulence in vivo. Both adhesion and invasion clearly involve the organism's unique tip-like structure. Invading mycoplasmas often have their tip-like structure deeply buried in the cytoplasm of infected mammalian cells. Extensive invasion of the mycoplasma into the cytoplasm may kill the cells. The same pathobiologic processes of adhesion and invasion using the specialized tip-like structure are found on the epithelium in the patient's urogenital tract infected by M. penetrans. Both in vitro and in vivo findings suggest a possible pathogenic role of this newly discovered human mycoplasma and call for careful evaluation of its role in human diseases.

Entities:  

Mesh:

Year:  1993        PMID: 8346175

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  26 in total

1.  The complete genomic sequence of Mycoplasma penetrans, an intracellular bacterial pathogen in humans.

Authors:  Yuko Sasaki; Jun Ishikawa; Atsushi Yamashita; Kenshiro Oshima; Tsuyoshi Kenri; Keiko Furuya; Chie Yoshino; Atsuko Horino; Tadayoshi Shiba; Tsuguo Sasaki; Masahira Hattori
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

2.  Mycoplasma infections and different human carcinomas.

Authors:  S Huang; J Y Li; J Wu; L Meng; C C Shou
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

3.  Role of Mycoplasma penetrans endonuclease P40 as a potential pathogenic determinant.

Authors:  M Bendjennat; A Blanchard; M Loutfi; L Montagnier; E Bahraoui
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

4.  Multiple promoter inversions generate surface antigenic variation in Mycoplasma penetrans.

Authors:  Atsuko Horino; Yuko Sasaki; Tsuguo Sasaki; Tsuyoshi Kenri
Journal:  J Bacteriol       Date:  2003-01       Impact factor: 3.490

5.  Pathogenicity of Mycoplasma fermentans and Mycoplasma penetrans in experimentally infected chicken embryos.

Authors:  M M Hayes; B J Li; D J Wear; S C Lo
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

6.  In vitro influence of Mycoplasma penetrans on activation of peripheral T lymphocytes from healthy donors or human immunodeficiency virus-infected individuals.

Authors:  Y Sasaki; A Blanchard; H L Watson; S Garcia; A Dulioust; L Montagnier; M L Gougeon
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

7.  Mycoplasma orale infection affects K+ and Cl- currents in the HSG salivary gland cell line.

Authors:  K T Izutsu; S Fatherazi; C M Belton; D Oda; F D Cartwright; G E Kenny
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-06       Impact factor: 2.416

8.  Binding of IgA by Mycoplasma penetrans.

Authors:  Awni Moussa; Ran Nir-Paz; Shlomo Rottem
Journal:  Curr Microbiol       Date:  2009-02-03       Impact factor: 2.188

9.  Mycoplasma gallisepticum invades chicken erythrocytes during infection.

Authors:  Gunther Vogl; Astrid Plaickner; Susan Szathmary; László Stipkovits; Renate Rosengarten; Michael P Szostak
Journal:  Infect Immun       Date:  2007-10-22       Impact factor: 3.441

10.  Invasion of Ureaplasma diversum in Hep-2 cells.

Authors:  Lucas Miranda Marques; Priscilla M Ueno; Melissa Buzinhani; Beatriz A Cortez; Renata L Neto; Maurício Yamaguti; Rosângela C Oliveira; Ana Márcia S Guimarães; Telma A Monezi; Antonio Carlos R Braga; Gláucia M Machado-Santelli; Jorge Timenetsky
Journal:  BMC Microbiol       Date:  2010-03-17       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.